Combination therapy with memantine and a ChEI has been found to delay institutionalization in patients with moderate to severe Alzheimer's disease. Higher doses of the ChEI, rivastigmine (13.3 mg/24 h), showed improved function and cognition compared with traditional lower dosing (4.6 mg/24 h).
Creative art classes, antipsychotic medications, increased video game time, < 6 hours of sleep nightly, and treatment with gabapentin 300 mg orally three times daily typically do not delay institutionalization of patients with moderate to severe Alzheimer's disease.
Learn more about memantine and ChEIs for patients with Alzheimer's disease.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Jasvinder P. Chawla, Shaheen E. Lakhan. Fast Five Quiz: Alzheimer's Disease Management - Medscape - Aug 22, 2023.